Nanopharm Ltd., an Aptar Pharma company and leader in contract research and development services for orally inhaled and nasal drug products (OINDPs), has announced plans to expand in order to better support increased customer needs.   The new facility in Cwmbran, Wales will create an estimated 60 new employment opportunities and allow Nanopharm to substantially increase its full services capacity, including the expansion of its formulation and analytical capabilities, to facilitate the rapid gro...